Suppr超能文献

κ-卡拉胶低聚糖通过深海酶缓解溃疡性结肠炎小鼠的炎症反应和调节肠道微生物群。

κ-Selenocarrageenan Oligosaccharides Prepared by Deep-Sea Enzyme Alleviate Inflammatory Responses and Modulate Gut Microbiota in Ulcerative Colitis Mice.

机构信息

Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.

Key Laboratory of Marine Eco-Environmental Science and Technology, First Institute of Oceanography, Ministry of Natural Resources, Qingdao 266061, China.

出版信息

Int J Mol Sci. 2023 Feb 28;24(5):4672. doi: 10.3390/ijms24054672.

Abstract

κ-Selenocarrageenan (KSC) is an organic selenium (Se) polysaccharide. There has been no report of an enzyme that can degrade κ-selenocarrageenan to κ-selenocarrageenan oligosaccharides (KSCOs). This study explored an enzyme, κ-selenocarrageenase (SeCar), from deep-sea bacteria and produced heterologously in , which degraded KSC to KSCOs. Chemical and spectroscopic analyses demonstrated that purified KSCOs in hydrolysates were composed mainly of selenium-galactobiose. Organic selenium foods through dietary supplementation could help regulate inflammatory bowel diseases (IBD). This study discussed the effects of KSCOs on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) in C57BL/6 mice. The results showed that KSCOs alleviated the symptoms of UC and suppressed colonic inflammation by reducing the activity of myeloperoxidase (MPO) and regulating the unbalanced secretion of inflammatory cytokines (tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-10). Furthermore, KSCOs treatment regulated the composition of gut microbiota, enriched the genera , and and inhibited , and . These findings proved that KSCOs obtained by enzymatic degradation could be utilized to prevent or treat UC.

摘要

κ-硒卡拉胶(KSC)是一种有机硒(Se)多糖。目前尚未有报道称有酶能将κ-硒卡拉胶降解为κ-硒卡拉胶低聚糖(KSCOs)。本研究从深海细菌中探索出一种酶,即κ-硒卡拉胶酶(SeCar),并在 中进行了异源表达,该酶能将 KSC 降解为 KSCOs。化学和光谱分析表明,水解产物中的纯化 KSCOs 主要由硒半乳糖二糖组成。通过膳食补充有机硒食品可以帮助调节炎症性肠病(IBD)。本研究探讨了 KSCOs 对葡聚糖硫酸钠(DSS)诱导的 C57BL/6 小鼠溃疡性结肠炎(UC)的影响。结果表明,KSCOs 通过降低髓过氧化物酶(MPO)活性和调节炎症细胞因子(肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6 和 IL-10)的不平衡分泌,缓解了 UC 的症状并抑制了结肠炎症。此外,KSCOs 处理还调节了肠道微生物群的组成,丰富了 、 和 属,并抑制了 、 和 属。这些发现证明,通过酶解获得的 KSCOs 可用于预防或治疗 UC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/778e/10003262/d72cd34971b3/ijms-24-04672-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验